These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

411 related items for PubMed ID: 26577755

  • 1. The relationship between long-acting reversible contraception and insurance coverage: a retrospective analysis.
    Broecker J, Jurich J, Fuchs R.
    Contraception; 2016 Mar; 93(3):266-72. PubMed ID: 26577755
    [Abstract] [Full Text] [Related]

  • 2. Long-Acting Reversible Contraceptive Uptake before and after the Affordable Care Act Contraceptive Mandate in Women Undergoing First Trimester Surgical Abortion.
    Bell KN, Meyn LA, Chen BA.
    Womens Health Issues; 2018 Mar; 28(4):301-305. PubMed ID: 29853173
    [Abstract] [Full Text] [Related]

  • 3. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
    Nelson HN, Thayer E, Bailey C, Leuenberger L, Lehman E, Chuang CH.
    Womens Health Issues; 2019 Mar; 29(5):370-375. PubMed ID: 31337530
    [Abstract] [Full Text] [Related]

  • 4. Long-acting reversible contraceptive acceptability and unintended pregnancy among women presenting for short-acting methods: a randomized patient preference trial.
    Hubacher D, Spector H, Monteith C, Chen PL, Hart C.
    Am J Obstet Gynecol; 2017 Feb; 216(2):101-109. PubMed ID: 27662799
    [Abstract] [Full Text] [Related]

  • 5. Changes in out-of-pocket payments for contraception by privately insured women during implementation of the federal contraceptive coverage requirement.
    Finer LB, Sonfield A, Jones RK.
    Contraception; 2014 Feb; 89(2):97-102. PubMed ID: 24332745
    [Abstract] [Full Text] [Related]

  • 6. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I, LARC Guideline Development Group.
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [Abstract] [Full Text] [Related]

  • 7. Choice of the levonorgestrel intrauterine device, etonogestrel implant or depot medroxyprogesterone acetate for contraception after aspiration abortion.
    Steinauer JE, Upadhyay UD, Sokoloff A, Harper CC, Diedrich JT, Drey EA.
    Contraception; 2015 Dec; 92(6):553-9. PubMed ID: 26093190
    [Abstract] [Full Text] [Related]

  • 8. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L, Bottura BF, Bahamondes MV, Gonçalves MP, Correia VM, Espejo-Arce X, Sousa MH, Monteiro I, Fernandes A.
    Hum Reprod; 2014 Oct 10; 29(10):2163-70. PubMed ID: 25085802
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Early Impact of the Affordable Care Act on Uptake of Long-acting Reversible Contraceptive Methods.
    Pace LE, Dusetzina SB, Keating NL.
    Med Care; 2016 Sep 10; 54(9):811-7. PubMed ID: 27213549
    [Abstract] [Full Text] [Related]

  • 12. Initiation and continuation of long-acting reversible contraception in the United States military healthcare system.
    Chiles DP, Roberts TA, Klein DA.
    Am J Obstet Gynecol; 2016 Sep 10; 215(3):328.e1-9. PubMed ID: 27005514
    [Abstract] [Full Text] [Related]

  • 13. Factors associated with short interpregnancy interval in women who plan postpartum LARC: a retrospective study.
    Harney C, Dude A, Haider S.
    Contraception; 2017 Mar 10; 95(3):245-250. PubMed ID: 27589883
    [Abstract] [Full Text] [Related]

  • 14. The Impact of the Affordable Care Act on Contraceptive Use and Costs among Privately Insured Women.
    Snyder AH, Weisman CS, Liu G, Leslie D, Chuang CH.
    Womens Health Issues; 2018 Mar 10; 28(3):219-223. PubMed ID: 29544988
    [Abstract] [Full Text] [Related]

  • 15. Cost Sharing and Utilization of Postpartum Intrauterine Devices and Contraceptive Implants Among Commercially Insured Women.
    Moniz MH, Soliman AB, Kolenic GE, Tilea A, Fendrick AM, Bell S, Dalton VK.
    Womens Health Issues; 2019 Mar 10; 29(6):465-470. PubMed ID: 31495642
    [Abstract] [Full Text] [Related]

  • 16. Long acting reversible contraception in adolescents with cardiovascular conditions.
    Amies Oelschlager AM, Micks EA, Debiec KE, Nizamic T, Mantrala MD, Prager SW.
    J Pediatr Adolesc Gynecol; 2014 Dec 10; 27(6):353-5. PubMed ID: 25256877
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.